BFFTF (Biofrontera AG) Sale Of Business : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biofrontera AG Sale Of Business?

Biofrontera AG's sale of business for the three months ended in Mar. 2024 was $0.00 Mil. It means Biofrontera AG gained $0.00 Mil from selling business. Biofrontera AG's sale of business for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2023 ), Biofrontera AG gained the same money from selling business in Mar. 2024 ($0.00 Mil).

Biofrontera AG Sale Of Business Historical Data

The historical data trend for Biofrontera AG's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofrontera AG Sale Of Business Chart

Biofrontera AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Business

Get a 7-Day Free Trial

25.35

4.32

Biofrontera AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Sale Of Business	Get a 7-Day Free Trial															-	-	-	-	-

Biofrontera AG Sale Of Business Calculation

The amount earned to sell business.

Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Biofrontera AG Sale Of Business Related Terms

Thank you for viewing the detailed overview of Biofrontera AG's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofrontera AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofrontera AG (OTCPK:BFFTF) » Definitions » Sale Of Business

Comparable Companies

Traded in Other Exchanges

B8FK:Germany

Address

Hemmelrather Weg 201, Leverkusen, NW, DEU, 51377

Website

https://www.biofrontera.com

Biofrontera AG is active in the field of healthcare. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.